Gadde Vijaya 4
4 · Guardant Health, Inc. · Filed Jun 22, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) Director Gadde Vijaya Exercises Options, Receives RSUs
What Happened
- Director Gadde Vijaya exercised/converted a derivative (reported as Code M) covering 4,203 shares and the same 4,203-derivative position was reported as disposed (both at $0). In addition, she was shown as acquiring a grant/award of 2,711 restricted stock units (RSUs) at $0. The transactions are reported for 2026-06-17; the Form 4 was filed on 2026-06-22.
Key Details
- Transaction date: June 17, 2026. Form 4 filed: June 22, 2026 (filed 5 calendar days / 3 business days after the transaction).
- Reported amounts/prices: 4,203 shares (Exercise/Conversion, $0); 4,203 shares (Disposed—derivative, $0); 2,711 RSUs granted (Acquired, $0).
- Reported dollar totals on the Form 4: $0 for each line (these reflect exercise/grant terms; market value would require multiplying by the stock price on the transaction date).
- Shares owned after transaction: Not specified in the information provided in this summary (not disclosed here).
- Footnotes from the filing:
- F1: The RSU award vested in full on the date of the 2026 Annual Meeting (June 17, 2026).
- F2: Not applicable for Restricted Stock Units.
- F3: The RSU award vests in full on the one‑year anniversary of the grant date (June 17, 2026) or at the Company’s next annual meeting, whichever is earlier.
- Timeliness: The Form 4 appears to have been filed later than the typical 2-business-day reporting window.
Context
- Derivative transactions: The filing shows an exercise/conversion of a derivative and a corresponding disposition of the derivative position; the filing does not report an open‑market sale of underlying common stock. Transactions showing $0 commonly reflect awards or zero‑strike arrangements; to assess dollar impact, multiply the underlying shares by Guardant Health’s market price on June 17, 2026.
- RSUs: The 2,711 RSUs are reported with vesting commentary (see footnotes); vested RSUs typically convert to shares subject to any tax withholding rules before final delivery.
- No inference about intent or company outlook should be drawn from these administrative or compensation‑related filings alone.
Insider Transaction Report
Form 4
Gadde Vijaya
Director
Transactions
- Exercise/Conversion
Common Stock
2026-06-17+4,203→ 28,517 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-06-17−4,203→ 0 totalExercise: $0.00→ Common Stock (4,203 underlying) - Award
Restricted Stock Units
[F3][F2]2026-06-17+2,711→ 2,711 totalExercise: $0.00→ Common Stock (2,711 underlying)
Footnotes (3)
- [F1]The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.
- [F2]Not applicable for Restricted Stock Units.
- [F3]The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.
Signature
/s/ John G. Saia, as attorney-in-fact for Vijaya Gadde|2026-06-22